Order results by:
Issue | Title | |
Vol 15, No 5 (2023) | Diagnosis and treatment of depression according to the functional recovery paradigm | Abstract similar documents |
G. M. Usov | ||
"... Since the appearance of the first antidepressants, ideas about the goals of long-term treatment ..." | ||
Vol 14, No 4 (2022) | Adherence to antidepressant therapy: clinical experience on the example of agomelatine | Abstract similar documents |
N. N. Petrova | ||
"... The review article provides data on the prevalence and treatment problems of depression ..." | ||
Vol 11, No 2 (2019) | Pathogenesis, clinical features, and treatments of depression in Parkinson's disease | Abstract similar documents |
I. V. Milyukhina | ||
"... Depression is the most common non-motor manifestation of Parkinson's disease (PD), which ..." | ||
Vol 1, No 2 (2009) | DEPRESSION IN CEREBROVASCULAR DISEASES | Abstract similar documents |
T. G. Voznesenskaya | ||
"... The paper discusses the topical problem of depression in cerebrovascular diseases. It shows its ..." | ||
Vol 4, No 4 (2012) | Poststroke depression: prevalence, pathogenesis, diagnosis, and treatment | Abstract similar documents |
Vladimir Anatolyevich Parfenov | ||
"... poststroke depression; the efficacy of antidepressants is actively being investigated. When depression ..." | ||
Vol 14, No 1 (2022) | Impact of different classes of antidepressants on sleep and wakefulness regulation in depression | Abstract similar documents |
G. M. Usov, D. Yu. Kolomytsev, L. M. Lomiashvili | ||
"... insomnia, are widespread in depression. Depressed patients have a lot of sleep complaints that are often ..." | ||
Vol 12, No 5 (2020) | The use of vortioxetine for depression in patients with Parkinson's disease in the early and advanced stages of the disease | Abstract similar documents |
I. V. Miliukhina | ||
"... Depression is one of the most common non-motor manifestations of Parkinson's disease (PD), which ..." | ||
Vol 13, No 1 (2021) | Depression during the COVID-19 pandemic (analysis of clinical cases) | Abstract similar documents |
I. Yu. Dorozhenok | ||
"... . The multifactorial stressor effect of the COVID-19 pandemic has provoked an exacerbation of depression in a male ..." | ||
Vol 15, No 2 (2023) | The use of antidepressants in neurological practice | Abstract similar documents |
V. A. Parfenov | ||
"... Antidepressants are widely used in neurological practice, and their use in stroke, Alzheimer ..." | ||
Vol 12, No 6 (2020) | Post-stroke depression and the abilities of antidepressants to enhance the effectiveness of neurorehabilitation | Abstract similar documents |
S. V. Kotov, E. V. Isakova, Yu. V. Egorova | ||
"... mortality rates. The question of the use of antidepressants in the treatment of post-stroke depression ..." | ||
Vol 11, No 1 (2019) | Antidepressant therapy in patients with cardiovascular diseases | Abstract similar documents |
V. E. Medvedev, E. A. Korovyakova, V. I. Frolova, E. V. Gushanskaya | ||
"... Depression is the most common form of mental illness in patients with cardiovascular diseases (CVD ..." | ||
Vol 13, No 3 (2021) | Depression treatment in women and men with bipolar affective disorder: a comparative study | Abstract similar documents |
N. A. Tyuvina, A. E. Stolyarova, V. V. Balabanova, K. M. Bunkova, E. N. Efremova | ||
"... Objective: to compare depression treatment efficacy with and without antidepressants (ADs) in men ..." | ||
Vol 9, No 4 (2017) | Somatic depression with cognitive impairment in a female patient with hypertension | Abstract PDF (Eng) similar documents |
B. A. Volel, D. V. Troshina | ||
"... The paper describes a clinical case of hypertension and somatic depression in a female patient ..." | ||
Vol 4, No 1 (2012) | Post-stroke depression: scientifically substantiated approaches to choosing therapy | Abstract similar documents |
Yulia Aleksandrovna Starchina | ||
"... depression (PSD), its pathogenetic mechanisms, and an association between stroke and depression. It gives ..." | ||
Vol 5, No 1 (2013) | Depression therapy optimization at the present stage of development of psychopharmacology | Abstract similar documents |
Dmitry Sergeyevich Danilov | ||
"... The paper presents current psychopharmacological approaches to therapy for depressions ..." | ||
Vol 7, No 1 (2015) | Antidepressants are selective serotonin neuronal reuptake inhibitors: 40-year history | Abstract similar documents |
D. S. Danilov | ||
"... of depressed patients with tricyclic antidepressants, and to formulate the serotonergic theory of depression ..." | ||
Vol 8, No 2 (2016) | Therapy for depression in bipolar affective disorder | Abstract similar documents |
N. A. Tyuvina, I. G. Korobkova | ||
"... Objective: to evaluate the efficiency and safety of different therapy regimens for depression ..." | ||
Vol 11, No 3 (2019) | The use of vortioxetine for the correction of depression in Parkinson's disease: an example of clinical cases | Abstract similar documents |
I. V. Miliukhina | ||
"... with identified depression receive timely treatment with antidepressants. PD complicated by depression ..." | ||
Vol 14, No 1 (2022) | Comparative evaluation of psychopharmacotherapy of atypical depression in bipolar and recurrent affective disorder, psychogenic depression | Abstract PDF (Eng) similar documents |
M. S. Verbitskaya, N. A. Tyuvina, Yu. G. Tyulpin, G. L. Krenkel | ||
"... Objective: to evaluate the treatment effectiveness for atypical depression (AtD) depending on its ..." | ||
Vol 15, No 5 (2023) | Depressive disorders and their pharmacotherapy in routine clinical practice | Abstract similar documents |
S. N. Mosolov, V. A. Parfenov, A. V. Amelin, V. E. Medvedev, V. D. Mendelevich, G. M. Usov, Yu. P. Sivolap, A. N. Bogolepova, E. A. Mkhitaryan, D. S. Petelin | ||
"... Depression is one of the most common medical causes of disability and mortality in patients of all ..." | ||
Vol 12, No 2 (2020) | Atypical depression: selection criteria, systematics, approaches to therapy | Abstract PDF (Eng) similar documents |
N. A. Tyuvina, M. S. Verbitskaya, A. E. Stolyarova | ||
"... The paper reviews Russian and foreign literature on atypical depression (AtD). It sets forth ..." | ||
Vol 3, No 1 (2011) | The differential diagnosis and treatment of depressive disorders in menopausal women | Abstract similar documents |
N. A. Tyuvina | ||
"... of the climacteric syndrome with concomitant mental disorders. Furthermore, various mental disorders, depressions ..." | ||
Vol 12, No 6 (2020) | Atypical depression in bipolar affective disorder: a clinical case study | Abstract similar documents |
M. S. Verbitskaya, N. A. Tyuvina, G. L. Krenkel, E. N. Efremova, A. E. Stolyarova | ||
"... Atypical depression (AtD) is contrasted with classical endogenous melancholic depression ..." | ||
Vol 11, No 3 (2019) | Cognitive impairment in depression and Alzheimer's disease: differential diagnosis and approaches to therapy | Abstract similar documents |
N. A. Tyuvina, S. V. Prokhorova, T. N. Maksimova, M. S. Verbitskaya | ||
"... the former occurs. Antidepressants are used to treat depression and depressive disorders in AD, by taking ..." | ||
Vol 11, No 4 (2019) | Clinical and functional remission assessment in patients with recurrent depression | Abstract similar documents |
N. N. Petrova | ||
"... . When choosing an antidepressant for the maintenance therapy of recurrent depression, its positive ..." | ||
Vol 9, No 1 (2017) | Comparison of the efficacy of the multimodal serotonergic antidepressants trazodone and vortioxetine in the treatment of patients with endogenous depression: A meta-analysis of double-blind randomized placebo-controlled trials | Abstract similar documents |
D. S. Danilov | ||
"... Selective serotonergic antidepressants with a miltimodal mechanism of action are a new group ..." | ||
Vol 3, No 2 (2011) | Role of melatonin in the treatment of depression | Abstract similar documents |
O. V. Kotova | ||
"... of affective disorders and the emergence of new antidepressants. About 80% of inpatients with depression and 70 ..." | ||
Vol 8, No 1 (2016) | The rationale for antidepressants in the treatment of schizophrenia: A modern view on the problem in the context of evidence-based medicine | Abstract similar documents |
D. S. Danilov, D. O. Magomedova, M. E. Matsneva | ||
"... The paper discusses whether antidepressant treatment is rational in schizophrenics. It analyzes ..." | ||
Vol 15, No 1 (2023) | Predictive capabilities of the Cloninger Temperament and Character Inventory (TCI) in evaluating the effectiveness of antidepressant pharmacotherapy. Systematic review and meta-analysis | Abstract similar documents |
A. V. Ovchinnikov, T. I. Vazagaeva, R. V. Akhapkin, B. A. Volel | ||
"... of antidepressant pharmacotherapy in patients with depression (major depressive disorder). Material and methods ..." | ||
Vol 5, No 2 (2013) | Irritable bowel syndrome in a psychiatristxs practice (the problem of nosological independence) and a possibility of its treatment with antidepressants (in case of paroxetine efficacy) | Abstract similar documents |
Dmitry Sergeyevich Danilov, V D Morozova, I G Korobkova, T V Lukyanova | ||
"... on comorbidity with depression, as well as on the efficiency of psychopharmacotherapy options. Particular ..." | ||
Vol 9, No 3 (2017) | A chronobiological approach to therapy for depression | Abstract similar documents |
M. Yu. Gerasimchuk | ||
"... of the existing genetic predisposition increases a risk for the occurrence and chronicity of depression. To solve ..." | ||
Vol 13, No 6 (2021) | Treatment of mixed anxiety and depressive disorder: results from a observational study of the efficacy and tolerability of agomelatine | Abstract similar documents |
D. S. Petelin, I. V. Niinoya, O. V. Sorokina, D. V. Troshina, O. N. Voskresenskaya, B. A. Volel | ||
"... of psychometric methods – the Hamilton Depression Scale, the Hamilton Anxiety Scale, and a short form of the SF-12 ..." | ||
Vol 15, No 2 (2023) | Depression in patients with cerebral microangiopathy | Abstract similar documents |
A. N. Bogolepova | ||
"... Cerebral microangiopathy (CMA) is one of the significant causes of depression in the elderly ..." | ||
Vol 12, No 4 (2020) | Depression and dementia: differentiation and comorbidity | Abstract similar documents |
V. Yu. Lobzin, A. Yu. Emelin | ||
"... The relationship between cognitive impairment (CI) and depression is complicated: hthe latter can ..." | ||
Vol 10, No 4 (2018) | Approaches to therapy for depressions in neurology: prospects for the use of agomelatine | Abstract similar documents |
D. V. Romanov, B. A. Volel, D. S. Petelin | ||
"... This review provides information on prospects for using the antidepressant agomelatine ..." | ||
Vol 10, No 4 (2018) | Serotonin and norepinephrine reuptake inhibitor antidepressants: a look through the prism of their 30-year history | Abstract similar documents |
D. S. Danilov | ||
"... (SNRI) antidepressants. Theoretical prerequisites for their emergence are described. The evaluation ..." | ||
Vol 12, No 6 (2020) | Somatization disorders of affective and neurotic registers during the COVID-19 pandemic (analysis of clinical cases) | Abstract similar documents |
I. Yu. Dorozhenok | ||
Vol 6, No 1 (2014) | Depression as a mask for dyscirculatory encephalopathy and its therapy | Abstract similar documents |
D.V. Neverovskiy, S.F. Sluchevskaya | ||
"... by a psychiatrist. Psychotherapy and antidepressant therapy led to significant improvement. The differential ..." | ||
Vol 12, No 5 (2020) | On the heterogeneity of depression in Parkinson’s disease | Abstract similar documents |
M. R. Nodel, N. N. Yakhno | ||
"... Depression in Parkinson’s disease (PD) is one of the leading manifestations of the disease, which ..." | ||
Vol 6, No 4 (2014) | Somatization of anxiety disorders in the practice of a neurologist: Algorithms and approaches to differentiated treatment | Abstract similar documents |
E. G. Mendelevich | ||
"... the experienced symptoms of anxiety or depression for the development of physical symptoms; anxiety disorders ..." | ||
Online-first | Predictive capabilities of the Temperament and Character Inventory (TCI) in assessing the effectiveness of antidepressant pharmacotherapy | Abstract similar documents |
A. V. Ovchinnikov, T. I. Vazagaeva, R. V. Akhapkin, B. A. Volel | ||
"... and Character Inventory (TCI) in assessing the results of antidepressant pharmacotherapy in patients ..." | ||
Vol 13, No 2 (2021) | Anxiety and depression in COVID-19: treatment options | Abstract similar documents |
V. E. Medvedev | ||
"... frequency of depression (up to 53.5%), anxiety (up to 50.9%), and mixed anxiety/depressive disorders were ..." | ||
Vol 12, No 1 (2020) | Experience with vortioxetine in the treatment of post-stroke depression | Abstract similar documents |
I. A. Strelnikova, A. A. Svetkina, Yu. D. Minina, O. V. Androfagina | ||
"... Post-stroke depression significantly impairs functional recovery in patients and their quality ..." | ||
Vol 11, No 2 (2019) | Tobacco smoking dependence in patients with depressive spectrum mental disorders: clinical, pathogenetic, and therapeutic aspects | Abstract similar documents |
O. I. Speranskaya, S. A. Trushchelev, Z. I. Storozheva | ||
"... affects the efficiency of treatment. Resistance to anti-nicotine and antidepressant medications ..." | ||
Vol 12, No 2 (2020) | Investigation of the efficiency of various antidepressant replacement regimens in the development of SSRI-induced apathy syndrome | Abstract similar documents |
V. E. Medvedev, R. A. Kardashyan, V. I. Frolova, A. M. Burno, S. V. Nekrasova, V. I. Salyntsev | ||
"... to develop symptoms of SSRI-induced apathy during SSRI antidepressant monotherapy for at least 6 months ..." | ||
Vol 12, No 4 (2020) | Depressions with eating disorders: clinical manifestations and therapy | Abstract similar documents |
V. E. Medvedev, V. I. Frolova, E. V. Gushanskaya, Yu. S. Fofanova, S. E. Martynov, N. L. Zuikova, A. M. Burno, S. V. Nekrasova, I. V. Salyntsev | ||
"... with the antidepressant agomelatine (25–50 mg/day at night) for depressions with two ED variants: hyperphagic (n=32 ..." | ||
Vol 3, No 2 (2011) | Depressions in patients with essential hypertension complicated by chronic heart failure | Abstract similar documents |
N. A. Tyuvina, V. A. Lyusov, S N Molchanov, D B Gaeva | ||
"... months after therapy with the antidepressant pyrazidole. Moderate depressive disorders reduced exercise ..." | ||
Vol 14, No 3 (2022) | Comorbidities and therapy for chronic non-specific low back pain and fibromyalgia | Abstract similar documents |
T. I. Nasonova, E. V. Parfenova | ||
"... a numerical rating scale (NRS), using the Hospital Anxiety and Depression Scale (HADS), the Screening ..." | ||
Vol 16, No 4 (2024) | Difficulties in the diagnosis of depression in somatic and neurological practice: clinical observation | Abstract similar documents |
N. A. Tyuvina, T. N. Maximova, S. V. Prokhorova, E. A. Kamelina | ||
"... Depression often develops on a background of somatic and neurological conditions ..." | ||
Vol 14, No 5 (2022) | Emotional disorders and their therapy in chronic low back pain | Abstract similar documents |
A. I. Isaikin, T. I. Nasonova, A. Kh. Mukhametzyanova | ||
"... , kinesiotherapy, and cognitive behavioral therapy. Antidepressants are prescribed for CLBP to reduce the severity ..." | ||
Vol 4, No 2 (2012) | Efficacy of paxil in the treatment of depressions in elderly males | Abstract similar documents |
N A Tyuvina, S V Prokhorova, T N Maksimova | ||
"... Objective: to study the efficacy of paxil in the treatment of depression of varying severity ..." | ||
Vol 16, No 6 (2024) | Antidepressant and anxiolytic efficacy and tolerability of agomelatine in the treatment of depression after COVID-19 in daily clinical practice (non-interventional study TELESPHOR) | Abstract similar documents |
V. E. Medvedev, A. N. Bogolepova, D. P. Morozov, B. B. Kvasnikov | ||
"... Depression and anxiety are among the most common disorders observed in patients after COVID-19 ..." | ||
Vol 16, No 6 (2024) | Comorbidity of sialorrhea and depression in patients with Parkinson's disease, their mutual influence on the severity of symptoms and the success of therapy | Abstract similar documents |
D. V. Zakharov, D. D. Kokareva | ||
"... Depression and sialorrhea are among the most common and distressing non-motor symptoms ..." | ||
Vol 11, No 2 (2019) | Differentiated approach and indications for optimization of agomelatine therapy for endogenous depression | Abstract similar documents |
L. I. Abramova, G. P. Panteleeva, I. Yu. Nikiforova, T. E. Novozhenova | ||
"... ) to treat the typological variants of endogenous depressions with varying severity on the basis ..." | ||
Vol 14, No 1 (2022) | Impact of endothelial inflammation on depression in patients with cerebral microangiopathy: a prospective study | Abstract similar documents |
O. V. Vorobyeva, A. A. Pilipovich, V. V. Fateeva | ||
"... Epidemiological studies demonstrate a strong relationship between depression and cerebral ..." | ||
Vol 2, No 4 (2010) | Depression in Parkinson's disease | Abstract similar documents |
M. R. Nodel' | ||
"... of not only motor, but also neuropsychic disorders. Depression occurs in an average of 40-50% of patients ..." | ||
Vol 14, No 4 (2022) | SSRI-associated apathy in Alzheimer's disease: a case series | Abstract similar documents |
D. S. Petelin, A. N. Gamirova, O. N. Voskresenskaya, B. A. Volel | ||
"... of psychotropic drugs commonly prescribed for AD, such as antidepressants of the SSRI class, may themselves cause ..." | ||
Vol 10, No 3 (2018) | Clinical features of depression in women compared with men | Abstract PDF (Eng) similar documents |
N. A. Tyuvina, E. O. Voronina, V. V. Balabanova, Yu. G. Tyulpin | ||
"... Objective: to study the clinical features of depression in women compared with men. Patients ..." | ||
Vol 11, No 3S (2019): Спецвыпуск: когнитивные нарушения, цереброваскулярные заболевания | Vascular depression and cognitive dysfunction | Abstract similar documents |
A. N. Bogolepova | ||
"... Vascular depression is a very frequent and serious complication of cerebrovascular diseases ..." | ||
Vol 1, No 3-4 (2009) | DEPRESSION AND CARDIOVASCULAR DISEASES | Abstract similar documents |
L. V. Romasenko | ||
"... According to the results of integrated assessment of cardiological inpatients with depression ..." | ||
Vol 16, No 4 (2024) | Agomelatine: pharmacological profile, possible application, advantages | Abstract similar documents |
V. E. Medvedev, O. V. Kotova, A. V. Palin, O. V. Mikheeva, E. S. Akarachkova | ||
"... Agomelatine is an antidepressant with a unique pharmacological action that is both a melatonin ..." | ||
Vol 15, No 4 (2023) | Experience with agomelatine therapy for non-psychotic depression with a single and recurrent course | Abstract similar documents |
L. A. Ivanova, A. V. Kovaleva, N. O. Sitnikova | ||
"... Therapy of depression is a current problem in psychiatry. Agomelatine is not inferior to other ..." | ||
Vol 11, No 1 (2019) | Cognitive impairment in primary hyperparathyroidism | Abstract similar documents |
N. G. Mokrysheva, Yu. A. Krupinova, E. E. Bibik, G. A. Melnichenko | ||
"... нейропсихологического состояния и качества жизни пациентов на фоне достижения нормокальциемии и снижения уровня ..." | ||
Vol 4, No 2S (2012): Сognitive and other neuropsychiatric disorders | Analysis of affective disorders in patients with vascular dementia | Abstract similar documents |
D. V. Zakharchenko, N. G. Neznanov, N. M. Zalutskaya | ||
Vol 12, No 2 (2020) | The history of mianserin and mirtazapine: study of their neurochemical activity and determination of their position in the classification of antidepressants | Abstract similar documents |
D. S. Danilov, Yu. G. Tyulpin, V. D. Morozova | ||
"... and mirtazapine. The concept of the development of the antidepressant effect of these drugs, by stimulating ..." | ||
Vol 9, No 3 (2017) | The typology and clinical features of depressions during a period of remission in paroxysmal schizophrenia | Abstract similar documents |
N. A. Tyuvina, D. O. Magomedova, V. D. Morozova | ||
"... Depressions in patients with schizophrenia in remission are quite common; however, their genesis ..." | ||
Vol 5, No 3 (2013) | Role of anxiety and depressive disorders in the genesis of psychosomatic disorders | Abstract similar documents |
Aleksandr Anatolyevich Shatenshtein | ||
"... of these groups, an increase in anxiety and depression aggravates autonomic dysregulation reflecting in the larger ..." | ||
Vol 5, No 2S (2013): Special issue "Stroke" | Use of escitalopram to prevent depression and cognitive impairments in the acute phase of stroke | Abstract similar documents |
Dina Rustemovna Khasanova, Yu V Zhitkova | ||
"... The purpose of the study was to comparatively analyze the rate of post-stroke depression ..." | ||
Vol 17, No 2 (2025) | Cognitive impairment in depression and cerebrovascular disease | Abstract similar documents |
I. V. Reverchuk | ||
"... and their combination. We discuss pathophysiological features of CI in depression, and possible therapeutic options ..." | ||
Vol 5, No 1 (2013) | Bipolar affective disorders: the specific features of the course and maintenance pharmacotherapy | Abstract similar documents |
Nina Arkadyevna Tyuvina, V N Smirnova | ||
1 - 70 of 309 Items | 1 2 3 4 5 > >> |
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)